Lissun, a single-specialty health-tech platform focused on children with special needs and developmental delays, has raised Rs 48 crore in a Series A funding round led by Colossa Ventures.
The round saw participation from Physis Capital and existing investors including RPSG Capital Ventures, Ivycap Ventures, Rainmatter, Multiply Ventures and SucSEED Ventures. New investors New Age India Fund and Beyond Capital Ventures also participated in the round.
The Gurugram-based startup had previously raised $2.5 million in a pre-Series A round led by RPSG Capital Ventures in September 2024. It also raised Rs 2.77 crore from Zerodha and other investors in June this year.
The fresh capital will be used to expand Sunshine by LISSUN centres in key cities, develop AI-led solutions using its proprietary technology and data, and strengthen clinical processes across its network, Lissun said in a press release.
Founded in 2021 by Krishna Veer Singh and Tarun Gupta, Lissun operates through its child-care brand Sunshine by LISSUN, which runs child development centres across India along with digital products and AI-led tools.
The company said it has grown fourfold over the past year and currently conducts more than 10,000 therapy sessions each month across 25 centres. It plans to expand its physical network to 50 centres by next year, while its digital products are targeted at reaching more than 10 lakh children over the coming years.
India is witnessing a growing need for advanced developmental and behavioral care for children, but access to high quality, consistent care remains sparse and fragmented. Lissun is bridging this gap through its child care brand, Sunshine by LISSUN, bringing together high-quality therapists and an AI-led ecosystem accessible both at centers and digitally.
Lissun competes with platforms such as Butterfly Learnings, Continua Kids, Hoola Health and Children First from Amaha.
The single-specialty health-tech segment focused on children with special needs and developmental delays has seen the emergence of startups working across early screening, diagnosis support, therapy and long-term developmental care for conditions including autism, ADHD, and speech and language disorders.
Butterfly Learnings raised Rs 32 crore in Series A funding in 2024, while CureAble secured Rs 2 crore in pre-seed funding in 2025. Gabify raised $175K in pre-seed funding in 2026. More recently, paediatric healthcare platform Hoola Health raised $5 million in 2026 and offers developmental assessments and therapy services as part of its child-focused care model.